Efficacy of calcium dobesilate in treating Chinese patients with mild-to-moderate non-proliferative diabetic retinopathy (CALM-DR): protocol for a single-blind, multicentre, 24-armed cluster-randomised, controlled trial

INTRODUCTION: Calcium dobesilate (CaD) has been used in the treatment of diabetic retinopathy (DR) due to its potential in protecting against retinal vascular damage. However, there is limited evidence exploring its efficacy in combating DR progression. This study is aimed at evaluating whether CaD...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Hao, Liu, Jiang, Wang, Duolao, Qiu, Shanhu, Yuan, Yang, Wang, Fenghua, Wen, Liang, Song, Qi, Sun, Zi-lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166613/
https://www.ncbi.nlm.nih.gov/pubmed/34049911
http://dx.doi.org/10.1136/bmjopen-2020-045256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166613/
https://www.ncbi.nlm.nih.gov/pubmed/34049911
http://dx.doi.org/10.1136/bmjopen-2020-045256

Ejemplares similares